Environmental, Social And Governance Report

Overview

The report describes Jacobson Pharma's FY2024 ESG strategy, including Board and ESG Committee oversight, a three-step materiality assessment, and alignment with five UN Sustainable Development Goals. Environmental disclosures report 19,800.59 tCO2-e of total Scope 1-3 emissions, a 61.90% decrease in GHG emissions intensity, and 33,694.11 MWh of total energy consumption. The Group reported 1,723 employees, 18,136 completed training hours, and zero work-related fatalities during the reporting period.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 April 2023 – 31 March 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services